PR NEWSWIRE

immediapress comunicato stampa

AtomVie Global Radiopharma Supplies the First Patient Dose of 225Ac-SSO110 for Ariceum Therapeutics' Phase 1/2 SANTANA-225 Clinical Trial in Extensive-Stage Small Cell Lung Cancer and Merkel Cell Carcinoma

HAMILTON, ON, Nov. 12, 2025 /PRNewswire/ -- AtomVie Global Radiopharma (AtomVie), a leading radiopharmaceutical CDMO, announced that it has successfully supplied the first dose of Ariceum Therapeutics' (Ariceum) 225Ac-SSO110, a potentially first- and best-in-class Actinium-225-labelled antagonist of ...

immediapress comunicato stampa

/C O R R E C T I O N -- EirGenix, Inc./

In the news release, EirGenix Signed The Commercial Licensinse Agreement for It's Second HER2 Biosimilar Asset EG1206A, issued 12-Nov-2025 by EirGenix, Inc. over PR Newswire, we are advised by the company that there are two typos in the headline. The complete, corrected release follows:

immediapress comunicato stampa

FOTON Charts a New Course for Global Commercial Vehicles

BEIJING, Nov. 12, 2025 /PRNewswire/ -- On November 9th, FOTON Motor held its 2026 Global Partners Conference in Beijing under the theme "DRIVE TO GREAT." The event gathered over 2,000 attendees from more than 140 countries to witness FOTON's major breakthroughs in product innovation and strategy, sho...



SEGUICI SUI SOCIAL

threads whatsapp linkedin twitter youtube facebook instagram

ora in
Prima pagina
articoli
in Evidenza